Elanco Animal Health IncorporatedELANNYSE
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank57
5Y CAGR-53.4%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-53.4%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.62% |
| Q3 2025 | -8.38% |
| Q2 2025 | 4.02% |
| Q1 2025 | 16.96% |
| Q4 2024 | -0.97% |
| Q3 2024 | -13.01% |
| Q2 2024 | -1.74% |
| Q1 2024 | 16.43% |
| Q4 2023 | -3.09% |
| Q3 2023 | 1.04% |
| Q2 2023 | -15.91% |
| Q1 2023 | 27.23% |
| Q4 2022 | -3.70% |
| Q3 2022 | -12.68% |
| Q2 2022 | -4.16% |
| Q1 2022 | 10.15% |
| Q4 2021 | -1.59% |
| Q3 2021 | -11.57% |
| Q2 2021 | 2.98% |
| Q1 2021 | 8.98% |
| Q4 2020 | 28.11% |
| Q3 2020 | 51.73% |
| Q2 2020 | -10.86% |
| Q1 2020 | -16.43% |
| Q4 2019 | 2.04% |
| Q3 2019 | -1.32% |
| Q2 2019 | 6.91% |
| Q1 2019 | -8.53% |
| Q4 2018 | 5.02% |
| Q3 2018 | -1.18% |
| Q2 2018 | 4.62% |
| Q1 2018 | -2.40% |
| Q4 2017 | 8.21% |
| Q3 2017 | -3.02% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |